Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Borrello

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|October 4, 2006
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cellsGiovanna Gallina, Luigi Dolcetti, Paolo Serafini, et al.
Molecular Cancer Therapeutics|August 29, 2012
Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapyAtul Bedi, Xiaofei Chang, Kimberly Noonan, et al.
Nature Medicine|June 5, 2003
Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cellsYan Cui, Erin Kelleher, Erin Straley, et al.
International Journal of Cardiology|October 22, 2020
Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohortAmish N Raval, Peter V Johnston, Henricus J Duckers, et al.
Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.
Cancer Research|January 4, 2008
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistanceWilliam Matsui, Qiuju Wang, James P Barber, et al.
British Journal of Haematology|October 21, 2011
Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour responseAsher A Chanan-Khan, Kasyapa Chitta, Noreen Ersing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2003
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cellsCarol Ann Huff, Ephraim J Fuchs, Stephen J Noga, et al.
Leukemia Research|February 12, 2008
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromesErica D Warlick, Paul V O'Donnell, Michael Borowitz, et al.
Leukemia & Lymphoma|July 16, 2011
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomasDouglas E Gladstone, Javier Bolaños-Meade, Carol Ann Huff, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|October 4, 2006
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cellsGiovanna Gallina, Luigi Dolcetti, Paolo Serafini, et al.
Molecular Cancer Therapeutics|August 29, 2012
Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapyAtul Bedi, Xiaofei Chang, Kimberly Noonan, et al.
Nature Medicine|June 5, 2003
Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cellsYan Cui, Erin Kelleher, Erin Straley, et al.
International Journal of Cardiology|October 22, 2020
Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohortAmish N Raval, Peter V Johnston, Henricus J Duckers, et al.
Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.
Cancer Research|January 4, 2008
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistanceWilliam Matsui, Qiuju Wang, James P Barber, et al.
British Journal of Haematology|October 21, 2011
Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour responseAsher A Chanan-Khan, Kasyapa Chitta, Noreen Ersing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2003
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cellsCarol Ann Huff, Ephraim J Fuchs, Stephen J Noga, et al.
Leukemia Research|February 12, 2008
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromesErica D Warlick, Paul V O'Donnell, Michael Borowitz, et al.
Leukemia & Lymphoma|July 16, 2011
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomasDouglas E Gladstone, Javier Bolaños-Meade, Carol Ann Huff, et al.
Pageof 9